Acutus Medical (Nasdaq:AFIB) announced today that it will lay off 65% of its workforce as part of a major restructuring. The Carlsbad, California–based company’s most recent annual report lists 225 workers at the end of 2022, which means the layoff could involve roughly 146 workers. Restructuring will involve winding down Acutus Medical’s EP mapping and […]
Medtronic
NICE recommends automated insulin delivery tech rollout in UK, Medtronic, Dexcom applaud
An independent committee of the National Institute for Health and Care Excellence (NICE) voiced support for closed-loop insulin delivery. The UK-based institute recommended offering automated insulin delivery (AID) for people whose type 1 diabetes is not controlled with their current device despite best possible management with an insulin pump or real-time or intermittently scanned continuous […]
Avail Medsystems abruptly shuts down
Avail Medsystems — which emerged from the pandemic as one of the leading companies building virtual connections between medical device sales reps and operating rooms — has shut down. Multiple sources have confirmed yesterday’s shutdown to MassDevice. People familiar with the company say Avail failed to close on a new round of capital necessary to […]
The biggest cardiovascular stories from TCT 2023
Every year, some of the biggest names in cardiovascular technologies come together in one place for TCT. This year’s 35th edition of the Transcatheter Cardiovascular Therapeutics annual scientific symposium was no different in San Francisco. Usual suspects like Medtronic and Abbott released data covering a range of products, while other big names like Edwards, GE […]
Medtronic Evolut TAVR outperforms surgical valve replacement in study
Medtronic today announced positive four-year results from a trial of its Evolut transcatheter aortic valve replacement (TAVR) system. Evolut TAVR demonstrated “exceptional outcomes and sustained valve performance,” Medtronic says. It showed significantly better hemodynamics than surgical aortic valve replacement (SAVR). The company presented the data at the 35th Transcatheter Cardiovascular Therapeutics (TCT) conference in San […]
Medtronic has positive Intrepid TMVR data
Medtronic shared positive data from a study of its Intrepid transcatheter mitral valve replacement (TMVR). The medtech giant presented one-year results from the Intrepid early feasibility study at TCT 2023. It simultaneously published the data in JACC: Cardiovascular Intervention. Medtronic says the study demonstrated the early benefits of the Intrepid TMVR-transfemoral system, maintained up to […]
Medtronic wins FDA nod for extravascular defibrillator
Medtronic announced today that the FDA approved its Aurora EV-ICD MRI SureScan extravascular defibrillator. The FDA granted approval for the Aurora system and the Epsila EV MRI SureScan defibrillation lead. They treat dangerously fast heart rhythms that can lead to sudden cardiac arrest (SCA). Medtronic says Aurora EV-ICD is the first to provide the benefits […]
How the new Medtronic CGM-insulin pen combo simplifies diabetes management
Medtronic named its next-generation “Simplera” continuous glucose monitor (CGM) as a nod to its simplicity. The company, which just initiated the system’s launch in Europe following CE mark approval, is exceedingly optimistic about the technology. Medtronic’s all-in-one, disposable CGM features a simple, two-step insertion process for people with diabetes using multiple daily injections (MDI). Its newest […]
Medtronic Evolut FX TAVI wins CE mark approval
Medtronic this week announced it received CE mark approval for the Evolut FX transcatheter aortic valve implantation system. The Evolut FX is the latest generation TAVI of the company’s CoreValve/Evolut TAVI platform. Medtronic designed it to enhance ease-of-use and provide greater precision and control throughout the procedure for clinicians treating patients with severe aortic stenosis. […]
How can medtech companies innovate their business models?
In an ever-changing medtech space, how do companies keep up with the pace of change? How do companies adjust and innovate their business models to reflect that? Leaders from some of medtech’s biggest names attempted to answer some questions around that at AdvaMed’s The MedTech Conference yesterday. (Want to find out more? Leaders from major […]
How Medtronic, Zimmer Biomet and Smith+Nephew approach medtech M&A
In a year with some massive acquisitions in medtech, there are still questions around an overall drop in M&A activity. According to Pete Cataldo, managing director and medtech head of Truist, deal volume in the sector fell 65% in the first half of 2023. However, despite high interest rates and a volatile stock market, there […]